Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FBRX
#3008
Forte Biosciences, Inc. Common Stock
32.355
0
USD
-0.20%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-0.20%
Mudança mensal
+19.88%
Mudança em 6 meses
+10.24%
Mudança anual
+10.24%
Fechamento anterior
32.420
0
Abrir
32.190
0
Bid
Ask
Mínimo
32.190
0
High
32.400
0
Volume
16
Mercados
Ações
Cuidados de saúde
FBRX
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
6.58 M
6.58 M
12.43 M
12.53 M
13.89 M
—
Valuation ratios
Enterprise value
127.23 M
—
54.61 M
94.49 M
301.71 M
—
Price to earnings ratio
-1.87
-0.82
-3.5
-107.14
-5.79
-117.26
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.12
-0.33
-0.1
-0.18
-0.3
-0.92
Return on equity %
-0.14
-0.41
-0.11
-0.21
-0.41
-1.14
Return on invested capital %
-11.1 K
—
—
—
-5 179.1
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.76
5.22
11.74
7.34
3.88
28.18
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Notícias
Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)
Forte Biosciences: Bull Run Could Continue Thanks To Near-Term Data Readouts
Forte Biosciences precifica oferta de ações de US$ 150 milhões a US$ 26,27 por ação
Forte Biosciences lança oferta pública de ações
Guggenheim reitera classificação de compra para Forte Biosciences antes de divulgação de dados
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know
Micron, Insmed among market cap stock movers on Thursday
Evercore ISI inicia cobertura da Forte Biosciences com classificação de Superar
Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating
Guggenheim initiates Forte Biosciences stock with Buy rating on autoimmune therapy potential
Forte Biosciences Announces Pricing of $75 Million Public Offering
Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data - TipRanks.com